NOTES ON THE EMERGING ACCREDITATION REGIMES IN AUSTRALIA AND NEW ZEALAND


Personalized biological treatment with lanadelumab in a patient with recurrent attacks of hereditary angioedema

Hereditary angioedema (HAE) is an autosomal dominantly inherited disease caused by deficiency of C1 esterase inhibitor protein type 1 (about 85% of Washing Machine Hose Clamp patients with HAE-C1-INH) or type 2 oedema (about 15% of patients with HAE-C1-INH) by C1 inhibitor dysfunction, with normal serum levels (HAE-2).Long-term treatment to prevent

read more